Ge Long Hui A P P·2026-02-27 14:20Core Viewpoint - Spring Medical (688236.SH) reported a significant increase in both revenue and net profit for the fiscal year 2025, indicating strong business performance and growth potential [1] Financial Performance - The company achieved total operating revenue of 1.044 billion yuan, representing a year-on-year growth of 29.52% [1] - The net profit attributable to the parent company was 272 million yuan, reflecting a substantial year-on-year increase of 117.72% [1] Business Development - The growth potential of the company's products has been continuously released following the implementation of centralized procurement [1] - The international business is steadily advancing, contributing to the overall revenue growth [1] - Internal and external collaboration has driven stable revenue growth [1] Operational Efficiency - The company has been optimizing its management and resource allocation, leading to improved operational efficiency and profitability [1] - These enhancements have collectively supported the achievement of strong performance growth [1]